Archives for October 10, 2023

← 2023

CRF study smashes diversity targets in trials with three times national average

10-Oct-2023

By Liza Laws

Complete clinical trials solution company, Hawthorne Effect, announced today (October 10) it had successfully recruited more than 1,000 patients in 48 states plus Hawaii for a study to qualify the prevalence of valvular heart disease (VHD).

‘Remarkable’ effect of evenamide, Newron's treatment-resistant schizophrenia (TRS) drug

10-Oct-2023

By Liza Laws

The unique glutamatergic mechanism of action in Newron Pharmaceuticals’ investigational new drug can potentially produce a long-lasting antipsychotic response in patients with TRS, and the benefits will accrue over time.